Business information

Health information company SurvivorNet launches innovative clinical trial search tool that uses AI to connect patients in need with groundbreaking cancer research

The SurvivorNet Clinical Trials Search Tool is built above clinicaltrials.gov and provides access to over 100,000 individual clinical trials, updated daily. Patients enter their information by answering questions using our personalized chat feature. When patients complete the form, they are connected to clinical trials in their region tailored to their individual condition through our proprietary AI. This provides multiple opportunities for clinical trial sponsors and clinical research organizations looking to engage with patients.

“Clinical trials are essential to the development of new therapies, and as we experience this extraordinary revolution in genomics, immunotherapy and targeted therapies, it is clear that one of the most pressing needs for patients, clinical trial sponsors and researchers is simply a better way to find patients,” said SurvivorNet CEO Steve Alperin. “Even one percent more people successfully enrolled in clinical trials can change the world,” he added.

SurvivorNet has 2.5 million people who come each month for better treatment information to help them make important treatment decisions. The new Clinical Trial Finder platform is a natural extension of what SurvivorNet does every day: providing powerful tools to help patients find the best options.

About SurvivorNet
SurvivorNet is the nation’s leading cancer information platform, serving 2.5 million people a month who seek help to make better decisions about their care. The platform was built in collaboration with leading comprehensive cancer centers and features top doctors providing highly detailed information on specific cancers. SurvivorNet has also produced thousands of stories intended to give hope and inspiration to patients.

Steve Alperin is the founder and CEO of SurvivorNet.

contacts:
For advertising: [email protected]
For sales and partnership: [email protected]

SOURCESurvivorNet